Date: 2016-02-18 12:07:01Biotechnology University of Toronto Emerging technologies Induced stem cells Stem cells Gene therapy University Health Network Toronto Western Research Institute Krembil Research Institute | | AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid LeuAdd to Reading ListSource URL: www.ccrm.caDownload Document from Source Website File Size: 223,64 KBShare Document on Facebook
|